METHOD treatment of autoimmune systemic diseases and medications

摘要

1. the application of u043au0441u0438u043cu0435u0434u043eu043du0430 hydrochloride u0434u043bu00a0 u043bu0435u0447u0435u043du0438u00a0 autoimmune u043fu043eu0440u0430u0436u0435u043du0438u00a0 bone and joint system diseases against the testimony to the u0441u0438u043cu0443u043bu044cu0442u0430u043du043du043eu0439 or planned u0441u043fu043bu0435 u043du044du043au0442u043eu043cu0438u0438.;2.method u043bu0435u0447u0435u043du0438u00a0 autoimmune lesions bone and joint system disease with evidence u0441u043fu043bu0435u043du044du043au0442u043eu043cu0438u0438, including the use of basic u0430u0434u0430u043fu0442u043eu0433u0435u043du043du044bu0445 lek u0430u0440u0441u0442u0432u0435u043du043du044bu0445 means u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, after u0441u043fu043bu0435u043du044du043au0442u043eu043cu0438u0438 as the basic drug hydrochloride u043au0441u0438u043cu0435u0434u043eu043du0430 means used in u0434u043eu043eu043fu0435u0440u0430u0446u0438u043eu043du043du044bu0439 peri from level 20 g within 7 - 10 days with continued during the postoperative period in the same doses up to 4 weeks, and the repetition rate in 2 - 3 u043cu0435u0441u00a0u0446u0430.